SCHEMBL6239738

SCHEMBL6239738

O=C1c2[nH]c3cc(Cl)ccc3c(=O)c2C(=O)N1Nc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
PIM1 P11309 4/20 0.46
CLK4 Q9HAZ1 3/20 0.46
CCNE2 O96020 1/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
CAMK2B Q13554 1/20 0.41
CAMK2G Q13555 1/20 0.41
CAMK2D Q13557 1/20 0.41
CAMK2A Q9UQM7 1/20 0.41
LMNA P02545 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
AXL P30530 1/20 0.40
PTK2B Q14289 1/20 0.40
MAPKAPK5 Q8IW41 1/20 0.40
SRPK1 Q96SB4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6231910 0.93 PIM1 (0.44) CA1CA2PIM1CLK4CCNE2
SCHEMBL6231904 0.90 CA1 (0.41) CA1CA2PIM1CLK4CCNE2
SCHEMBL6231125 0.89 PIM1 (0.47) CA1CA2PIM1CLK4CCNE2
SCHEMBL6232252 0.88 LMNA (0.42) CA1CA2PIM1CLK4LMNA
SCHEMBL6233755 0.86 PIM1 (0.40) CA1CA2PIM1CLK4LMNA
SCHEMBL6233754 0.86 MAPK13 (0.40) CA1CA2LMNAMAPTNPSR1
SCHEMBL6233199 0.85 CYP19A1 (0.42) CA1CA2PIM1CLK4CDK4
SCHEMBL6232106 0.84 CYP1A2 (0.41) LMNAALDH1A1HPGDCYP1A2HCRTR1
SCHEMBL6232338 0.84 CA1 (0.44) CA1CA2PIM1CLK4CCNE2
SCHEMBL6231824 0.82 TUBB4A (0.42) CA1CA2PIM1CLK4CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1004582-B1 Pyridazino quinoline compounds ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
EP-0790996-B1 PYRIDAZINOQUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2002-03-27 EP disclosed
US-6232313-B1 TREATING STROKE OR EPILEPTIC CONVULSIONS ASSOCIATED WITH EXCESSIVE CALCIUM INFLUX IN THE BRAIN CAUSED BY EXCITATORY AMINO ACIDS ZENECA LIMITED (GB) 2001-05-15 US disclosed
US-6214826-B1 NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 2001-04-10 US disclosed
EP-0724583-B1 PYRIDAZINO QUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2000-12-13 EP disclosed
EP-1004582-A2 Pyridazino quinoline compounds AstraZeneca UK Limited (GB) 2000-05-31 EP disclosed
US-5744471-A NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 1998-04-28 US disclosed
EP-0790996-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1997-08-27 EP disclosed
EP-0724583-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-08-07 EP disclosed
WO-1996015127-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-05-23 WO disclosed
WO-1995011244-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1995-04-27 WO disclosed